About Index Trending news
Analyze
Top 50 Pricing
Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals, Inc.

Work at Concert Pharmaceuticals, Inc.? Add yourself to this profile

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals is a biotechnology company utilizing deuterium to develop novel medical candidates.

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding Show all
Venture capital (Series C)
$37,000,000
Adage Capital Management, Flagship Ventures, Greylock Partners, +9
Venture capital (Series B)
$48,500,000
Employees

Team size

50+
$48,500,000 Venture capital (Series B)
PE HUB

Concert Pharma Raises $48.5 Million